Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

Effects of glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, on markers of liver status in patients with short bowel syndrome: findings from a randomised phase 2 trial.

Naimi RM, Hvistendahl M, Nerup N, Ambrus R, Achiam MP, Svendsen LB, Grønbæk H, Møller HJ, Vilstrup H, Steensberg A, Jeppesen PB.

EBioMedicine. 2019 Jul 17. pii: S2352-3964(19)30451-7. doi: 10.1016/j.ebiom.2019.07.016. [Epub ahead of print]

2.

Glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, for patients with short bowel syndrome: a randomised phase 2 trial.

Naimi RM, Hvistendahl M, Enevoldsen LH, Madsen JL, Fuglsang S, Poulsen SS, Kissow H, Pedersen J, Nerup N, Ambrus R, Achiam MP, Svendsen LB, Holst JJ, Hartmann B, Hansen SH, Dragsted LO, Steensberg A, Mouritzen U, Hansen MB, Jeppesen PB.

Lancet Gastroenterol Hepatol. 2019 May;4(5):354-363. doi: 10.1016/S2468-1253(19)30077-9. Epub 2019 Mar 15.

PMID:
30880176
3.

Danegaptide for primary percutaneous coronary intervention in acute myocardial infarction patients: a phase 2 randomised clinical trial.

Engstrøm T, Nepper-Christensen L, Helqvist S, Kløvgaard L, Holmvang L, Jørgensen E, Pedersen F, Saunamaki K, Tilsted HH, Steensberg A, Fabricius S, Mouritzen U, Vejlstrup N, Ahtarovski KA, Göransson C, Bertelsen L, Kyhl K, Olivecrona G, Kelbæk H, Lassen JF, Køber L, Lønborg J.

Heart. 2018 Oct;104(19):1593-1599. doi: 10.1136/heartjnl-2017-312774. Epub 2018 Mar 30.

PMID:
29602883
4.

Visual field defects after temporal lobe resection for epilepsy.

Steensberg AT, Olsen AS, Litman M, Jespersen B, Kolko M, Pinborg LH.

Seizure. 2018 Jan;54:1-6. doi: 10.1016/j.seizure.2017.11.011. Epub 2017 Nov 20.

5.

Can DMCO Detect Visual Field Loss in Neurological Patients? A Secondary Validation Study.

Olsen AS, Steensberg AT, la Cour M, Kjaer TW, Damato B, Pinborg LH, Kolko M.

Ophthalmic Res. 2017;58(2):85-93. doi: 10.1159/000468942. Epub 2017 May 24.

PMID:
28535498
6.

Bystander capability to activate speaker function for continuous dispatcher assisted CPR in case of suspected cardiac arrest.

Steensberg AT, Eriksen MM, Andersen LB, Hendriksen OM, Larsen HD, Laier GH, Thougaard T.

Resuscitation. 2017 Jun;115:52-55. doi: 10.1016/j.resuscitation.2017.04.002. Epub 2017 Apr 4.

PMID:
28385640
7.

Beyond biomarkers in drug discovery and development.

Steensberg A, Simons TD.

Drug Discov Today. 2015 Mar;20(3):289-91. doi: 10.1016/j.drudis.2014.12.009. Epub 2014 Dec 23. No abstract available.

8.

Metabolic impact of growth hormone treatment in short children born small for gestational age.

Lebl J, Lebenthal Y, Kolouskova S, Steensberg A, Jøns K, Kappelgaard AM, Ibáñez L, Phillip M.

Horm Res Paediatr. 2011;76(4):254-61. doi: 10.1159/000329729. Epub 2011 Sep 2.

9.

Source and kinetics of interleukin-6 in humans during exercise demonstrated by a minimally invasive model.

Toft AD, Falahati A, Steensberg A.

Eur J Appl Physiol. 2011 Jul;111(7):1351-9. doi: 10.1007/s00421-010-1755-5. Epub 2010 Dec 10.

PMID:
21153418
10.

Interleukin-6 autoantibodies are involved in the pathogenesis of a subset of type 2 diabetes.

Fosgerau K, Galle P, Hansen T, Albrechtsen A, Rieper Cde L, Pedersen BK, Larsen LK, Thomsen AR, Pedersen O, Hansen MB, Steensberg A.

J Endocrinol. 2010 Mar;204(3):265-73. doi: 10.1677/JOE-09-0413. Epub 2009 Dec 16.

PMID:
20016056
11.

European multicentre study in children born small for gestational age with persistent short stature: comparison of continuous and discontinuous growth hormone treatment regimens.

Phillip M, Lebenthal Y, Lebl J, Zuckerman-Levin N, Korpal-Szczyrska M, Marques JS, Steensberg A, Jons K, Kappelgaard AM, Ibanez L; European Norditropin SGA Study Group.

Horm Res. 2009 Jan;71(1):52-9. doi: 10.1159/000173742. Epub 2008 Nov 27.

PMID:
19039237
12.

Interleukin-6 markedly decreases skeletal muscle protein turnover and increases nonmuscle amino acid utilization in healthy individuals.

van Hall G, Steensberg A, Fischer C, Keller C, Møller K, Moseley P, Pedersen BK.

J Clin Endocrinol Metab. 2008 Jul;93(7):2851-8. doi: 10.1210/jc.2007-2223. Epub 2008 Apr 22.

PMID:
18430776
13.

Nitric oxide production is a proximal signaling event controlling exercise-induced mRNA expression in human skeletal muscle.

Steensberg A, Keller C, Hillig T, Frøsig C, Wojtaszewski JF, Pedersen BK, Pilegaard H, Sander M.

FASEB J. 2007 Sep;21(11):2683-94. Epub 2007 Apr 30.

PMID:
17470570
14.

Differential regulation of IL-6 and TNF-alpha via calcineurin in human skeletal muscle cells.

Keller C, Hellsten Y, Steensberg A, Pedersen BK.

Cytokine. 2006 Nov;36(3-4):141-7. Epub 2007 Jan 2.

PMID:
17197194
15.

Muscle and blood metabolites during a soccer game: implications for sprint performance.

Krustrup P, Mohr M, Steensberg A, Bencke J, Kjaer M, Bangsbo J.

Med Sci Sports Exerc. 2006 Jun;38(6):1165-74.

PMID:
16775559
16.

Cerebrospinal fluid IL-6, HSP72, and TNF-alpha in exercising humans.

Steensberg A, Dalsgaard MK, Secher NH, Pedersen BK.

Brain Behav Immun. 2006 Nov;20(6):585-9. Epub 2006 May 2.

PMID:
16647242
17.

Effect of exercise, training, and glycogen availability on IL-6 receptor expression in human skeletal muscle.

Keller C, Steensberg A, Hansen AK, Fischer CP, Plomgaard P, Pedersen BK.

J Appl Physiol (1985). 2005 Dec;99(6):2075-9. Epub 2005 Aug 11.

18.

Interleukin-6 receptor expression in contracting human skeletal muscle: regulating role of IL-6.

Keller P, Penkowa M, Keller C, Steensberg A, Fischer CP, Giralt M, Hidalgo J, Pedersen BK.

FASEB J. 2005 Jul;19(9):1181-3. Epub 2005 Apr 18. Retraction in: FASEB J. 2014 Mar;28(3):1526.

PMID:
15837717
19.

Interleukin-6 infusion during human endotoxaemia inhibits in vitro release of the urokinase receptor from peripheral blood mononuclear cells.

Ostrowski SR, Plomgaard P, Fischer CP, Steensberg AS, Møller K, Høyer-Hansen G, Pedersen BK, Ullum H.

Scand J Immunol. 2005 Feb;61(2):197-206.

20.

Leptin gene expression and systemic levels in healthy men: effect of exercise, carbohydrate, interleukin-6, and epinephrine.

Keller P, Keller C, Steensberg A, Robinson LE, Pedersen BK.

J Appl Physiol (1985). 2005 May;98(5):1805-12. Epub 2005 Jan 7.

21.

Does the aging skeletal muscle maintain its endocrine function?

Pedersen M, Steensberg A, Keller C, Osada T, Zacho M, Saltin B, Febbraio MA, Pedersen BK.

Exerc Immunol Rev. 2004;10:42-55.

22.

Glucose ingestion attenuates the exercise-induced increase in circulating heat shock protein 72 and heat shock protein 60 in humans.

Febbraio MA, Mesa JL, Chung J, Steensberg A, Keller C, Nielsen HB, Krustrup P, Ott P, Secher NH, Pedersen BK.

Cell Stress Chaperones. 2004 Winter;9(4):390-6.

23.

Exercise induces interleukin-8 expression in human skeletal muscle.

Akerstrom T, Steensberg A, Keller P, Keller C, Penkowa M, Pedersen BK.

J Physiol. 2005 Mar 1;563(Pt 2):507-16. Epub 2004 Dec 23. Retraction in: J Physiol. 2011 Jul 1;589(Pt 13):3407.

24.

Cerebral ammonia uptake and accumulation during prolonged exercise in humans.

Nybo L, Dalsgaard MK, Steensberg A, Møller K, Secher NH.

J Physiol. 2005 Feb 15;563(Pt 1):285-90. Epub 2004 Dec 20.

25.

The metabolic role of IL-6 produced during exercise: is IL-6 an exercise factor?

Pedersen BK, Steensberg A, Fischer C, Keller C, Keller P, Plomgaard P, Wolsk-Petersen E, Febbraio M.

Proc Nutr Soc. 2004 May;63(2):263-7. Review.

PMID:
15294041
26.

Standing up to the challenge of standing: a siphon does not support cerebral blood flow in humans.

Dawson EA, Secher NH, Dalsgaard MK, Ogoh S, Yoshiga CC, González-Alonso J, Steensberg A, Raven PB.

Am J Physiol Regul Integr Comp Physiol. 2004 Oct;287(4):R911-4. Epub 2004 Jun 10.

27.

The role of IL-6 in exercise-induced immune changes and metabolism.

Steensberg A.

Exerc Immunol Rev. 2003;9:40-7. Review.

PMID:
14686093
28.

Searching for the exercise factor: is IL-6 a candidate?

Pedersen BK, Steensberg A, Fischer C, Keller C, Keller P, Plomgaard P, Febbraio M, Saltin B.

J Muscle Res Cell Motil. 2003;24(2-3):113-9. Review.

PMID:
14609022
29.

Interleukin-6 production by contracting human skeletal muscle: autocrine regulation by IL-6.

Keller P, Keller C, Carey AL, Jauffred S, Fischer CP, Steensberg A, Pedersen BK.

Biochem Biophys Res Commun. 2003 Oct 17;310(2):550-4.

PMID:
14521945
30.

Interleukin-6 response to exercise during acute and chronic hypoxia.

Lundby C, Steensberg A.

Eur J Appl Physiol. 2004 Jan;91(1):88-93. Epub 2003 Sep 4.

PMID:
12955521
31.

Skeletal muscle interleukin-6 and tumor necrosis factor-alpha release in healthy subjects and patients with type 2 diabetes at rest and during exercise.

Febbraio MA, Steensberg A, Starkie RL, McConell GK, Kingwell BA.

Metabolism. 2003 Jul;52(7):939-44.

PMID:
12870175
32.

IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans.

Steensberg A, Fischer CP, Keller C, Møller K, Pedersen BK.

Am J Physiol Endocrinol Metab. 2003 Aug;285(2):E433-7.

33.

Hepatosplanchnic clearance of interleukin-6 in humans during exercise.

Febbraio MA, Ott P, Nielsen HB, Steensberg A, Keller C, Krustrup P, Secher NH, Pedersen BK.

Am J Physiol Endocrinol Metab. 2003 Aug;285(2):E397-402.

34.

Interleukin-6 stimulates lipolysis and fat oxidation in humans.

van Hall G, Steensberg A, Sacchetti M, Fischer C, Keller C, Schjerling P, Hiscock N, Møller K, Saltin B, Febbraio MA, Pedersen BK.

J Clin Endocrinol Metab. 2003 Jul;88(7):3005-10.

PMID:
12843134
35.

Glucose ingestion attenuates interleukin-6 release from contracting skeletal muscle in humans.

Febbraio MA, Steensberg A, Keller C, Starkie RL, Nielsen HB, Krustrup P, Ott P, Secher NH, Pedersen BK.

J Physiol. 2003 Jun 1;549(Pt 2):607-12. Epub 2003 Apr 17.

36.

Muscle-derived interleukin-6: lipolytic, anti-inflammatory and immune regulatory effects.

Pedersen BK, Steensberg A, Keller P, Keller C, Fischer C, Hiscock N, van Hall G, Plomgaard P, Febbraio MA.

Pflugers Arch. 2003 Apr;446(1):9-16. Epub 2003 Feb 18. Review.

PMID:
12690457
37.

The yo-yo intermittent recovery test: physiological response, reliability, and validity.

Krustrup P, Mohr M, Amstrup T, Rysgaard T, Johansen J, Steensberg A, Pedersen PK, Bangsbo J.

Med Sci Sports Exerc. 2003 Apr;35(4):697-705.

PMID:
12673156
38.

Acute interleukin-6 administration does not impair muscle glucose uptake or whole-body glucose disposal in healthy humans.

Steensberg A, Fischer CP, Sacchetti M, Keller C, Osada T, Schjerling P, van Hall G, Febbraio MA, Pedersen BK.

J Physiol. 2003 Apr 15;548(Pt 2):631-8. Epub 2003 Mar 14.

39.

Exercise and hypoxia: effects on leukocytes and interleukin-6-shared mechanisms?

Pedersen BK, Steensberg A.

Med Sci Sports Exerc. 2002 Dec;34(12):2004-13. Review.

PMID:
12471309
40.

Exercise induces hepatosplanchnic release of heat shock protein 72 in humans.

Febbraio MA, Ott P, Nielsen HB, Steensberg A, Keller C, Krustrup P, Secher NH, Pedersen BK.

J Physiol. 2002 Nov 1;544(3):957-62.

41.

IL-6 and TNF-alpha expression in, and release from, contracting human skeletal muscle.

Steensberg A, Keller C, Starkie RL, Osada T, Febbraio MA, Pedersen BK.

Am J Physiol Endocrinol Metab. 2002 Dec;283(6):E1272-8. Epub 2002 Aug 20.

42.

IL-6 activates HSP72 gene expression in human skeletal muscle.

Febbraio MA, Steensberg A, Fischer CP, Keller C, Hiscock N, Pedersen BK.

Biochem Biophys Res Commun. 2002 Sep 6;296(5):1264-6.

PMID:
12207910
43.

Muscle glycogen content and glucose uptake during exercise in humans: influence of prior exercise and dietary manipulation.

Steensberg A, van Hall G, Keller C, Osada T, Schjerling P, Pedersen BK, Saltin B, Febbraio MA.

J Physiol. 2002 May 15;541(Pt 1):273-81.

44.

Influence of pre-exercise muscle glycogen content on exercise-induced transcriptional regulation of metabolic genes.

Pilegaard H, Keller C, Steensberg A, Helge JW, Pedersen BK, Saltin B, Neufer PD.

J Physiol. 2002 May 15;541(Pt 1):261-71.

45.

Prolonged exercise, lymphocyte apoptosis and F2-isoprostanes.

Steensberg A, Morrow J, Toft AD, Bruunsgaard H, Pedersen BK.

Eur J Appl Physiol. 2002 May;87(1):38-42. Epub 2002 Mar 14.

PMID:
12012074
46.

Reduced glycogen availability is associated with an elevation in HSP72 in contracting human skeletal muscle.

Febbraio MA, Steensberg A, Walsh R, Koukoulas I, van Hall G, Saltin B, Pedersen BK.

J Physiol. 2002 Feb 1;538(Pt 3):911-7.

47.

Interleukin-6 production in contracting human skeletal muscle is influenced by pre-exercise muscle glycogen content.

Steensberg A, Febbraio MA, Osada T, Schjerling P, van Hall G, Saltin B, Pedersen BK.

J Physiol. 2001 Dec 1;537(Pt 2):633-9.

48.

Transcriptional activation of the IL-6 gene in human contracting skeletal muscle: influence of muscle glycogen content.

Keller C, Steensberg A, Pilegaard H, Osada T, Saltin B, Pedersen BK, Neufer PD.

FASEB J. 2001 Dec;15(14):2748-50. Epub 2001 Oct 29.

PMID:
11687509
49.

"Ox in boots:" an expression in the Sumerian farmer's instruction elucidated by later evidence.

Steensberg A.

Hist Med Vet. 1999;24(1):20-8. No abstract available.

PMID:
11623711
50.

Muscle-derived interleukin-6: possible biological effects.

Pedersen BK, Steensberg A, Schjerling P.

J Physiol. 2001 Oct 15;536(Pt 2):329-37. Review.

Supplemental Content

Loading ...
Support Center